Join us in-person or online for this CME symposium held as part of the
ATS 2025 International Conference
Pre-registration required.
Dinner will be served for in-person attendees. Seating is limited.
Sunday, May 18, 2025
6-6:30 p.m. (PDT): Check in and Dinner
6:30-8 p.m. (PDT): Educational Program
San Francisco Marriott Marquis
Golden Gate Ballroom A/B
710 Mission Street, San Francisco, CA 94103
Add event to calendar
(Opens in a new window) 
(Opens in a new window) 
(Opens in a new window) 
(Opens in a new window) 
(Opens in a new window) 
(Opens in a new window)
Epithelial-driven inflammatory airway diseases including CRSwNP, asthma, COPD, and allergic rhinitis are characterized by their heterogeneous nature and complex pathophysiology. Traditionally, these upper and lower airway diseases have been managed independently, often leading to suboptimal patient care.
In this CME symposium, experts in pulmonology, allergy and otolaryngology will explore the complexities of epithelial-driven inflammatory airway diseases and how epithelial cytokines play a role in shaping disease severity. The expert panel will discuss the importance of managing upper and lower inflammatory airway diseases together and how the evolving treatment landscape may affect clinical practice. Clinical case scenarios will illustrate strategies for personalizing treatment plans to improve outcomes for patients with comorbid upper and lower airway diseases.
Target Audience:
Pulmonologists, allergists/immunologists, otolaryngologists, rhinologists, and advanced practice providers.
Program Faculty:
Vamsi Guntur, MD, MSc
Professor
Department of Medicine
Division of Pulmonary, Critical Care & Sleep Medicine
National Jewish Health
Denver, CO
Flavia Cecilia Lega Hoyte, MD
Professor
Director, Allergy & Clinical Immunology Fellowship
Department of Medicine
Division of Allergy & Clinical Immunology
National Jewish Health
Denver, CO
Ash Khanwalkar, MD
Assistant Professor
Otolaryngology
Division of Specialty Service
National Jewish Health
Denver, CO
Accreditation and Designation Statements:
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Contact:
For questions, please call the Office of Professional Education at National Jewish Health at 303.398.1000 or 800.844.2305, or email ProEd@njhealth.org.
Support:
Supported by an Educational Grant from AstraZeneca.
Registration Information:
If interested in attending, please register below. This CME symposium is complimentary for both in-person and livestream attendees.
In-Person:
- In-person attendees must be registered as part of the ATS 2025 International Conference to attend this event.
- In-person attendees may begin arriving at 6pm for check-in and dinner. After 6:20pm, spots may be released to the waiting list.
- Please arrive early, as seating and food may be limited.
Online:
- Online attendees do not need to be registered as part of the ATS 2025 International Conference to attend this online event.
- Online attendees will receive the link to view the live symposium in the days leading up to the event.
Add event to calendar